Vanda Ruling Opens Door For Contesting FDA Drug Denials

By Chad Landmon, Claire Davies and Suzanne Bassett · September 24, 2025, 6:17 PM EDT

Since the U.S. Supreme Court's Loper Bright decision last year, one question that is often asked is whether companies will more aggressively challenge U.S. Food and Drug Administration product approval denials...

To view the full article, register now.